Dare Bioscience (DARE) Misses Q1 EPS by 20c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $15.45 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Morgan Stanley continues to recommend exposure to the broadening theme
• Roadzen posts 42% revenue jump in Q4 as annual sales hit $55M
• Nano Nuclear In Early Investment Talks From UAE Firm - Semafor